Novo Nordisk A/S
NVO
$74.34
-$3.77-4.83%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 4.03B | 4.02B | 2.89B | 3.70B | 3.17B |
| Total Depreciation and Amortization | 11.58M | 316.82M | 453.79M | 424.30M | 94.56M |
| Total Amortization of Deferred Charges | 36.44M | -- | -- | -- | 30.75M |
| Total Other Non-Cash Items | -2.18B | 3.78B | 2.63B | -750.60M | -355.42M |
| Change in Net Operating Assets | -140.20M | -1.66B | 1.31B | -1.29B | -1.56B |
| Cash from Operations | 1.76B | 6.46B | 7.29B | 2.08B | 1.38B |
| Capital Expenditure | -2.30B | -1.79B | -1.51B | -1.23B | -1.36B |
| Sale of Property, Plant, and Equipment | -142.90K | 147.40K | -- | -- | -- |
| Cash Acquisitions | -11.65B | 0.00 | -96.39M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 911.93M | -1.29B | -1.38B | 1.81B | -766.57M |
| Cash from Investing | -13.04B | -3.08B | -2.99B | 576.02M | -2.12B |
| Total Debt Issued | 44.76B | 119.00M | 34.51B | -- | -- |
| Total Debt Repaid | -433.00M | -532.00M | -5.05B | -317.00M | -355.00M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -7.49B | -2.41B | -7.45B | -2.84B | -9.76B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00 | -2.30B | 0.00 | -4.16B | 0.00 |
| Other Financing Activities | -- | -- | -5.33B | 5.33B | -- |
| Cash from Financing | 5.26B | -2.71B | 2.41B | -3.84B | -1.46B |
| Foreign Exchange rate Adjustments | 102.47M | -51.28M | 6.06M | 6.41M | -30.17M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.91B | 618.46M | 6.71B | -1.17B | -2.24B |
